{"id":"https://genegraph.clinicalgenome.org/r/30f306ce-c467-4e76-a117-2082cea14aafv1.1","type":"EvidenceStrengthAssertion","dc:description":["*NFATC2* was reported in relation to autosomal dominant congenital heart disease in 2014 (Briand-Suleau, A et al., PMID: 24486774). No genetic evidence linking *NFATC2* was identified in the literature or elsewhere. Genetic cases of *NFATC2* were seen to be a player in the congenital heart defects in patients with the 20q13.2 duplication along with *SALL4* (PMID: 24486774). \n\nFunctional alteration experimental evidence analyzed the mRNA levels in candidate CHD genes in the right ventricular myocardium of TOF cases and normal controls. Evidence found that  higher methylation of *NFATC2* might constitute a CpG island methylator phenotype for TOF disease (PMID: 24479926). In summary, the evidence supporting the relationship between *NFATC2* and autosomal dominant congenital heart disease has been disputed and no valid evidence remains to support the claim. More evidence is needed to either support or entirely refute the role *NFATC2* plays in this disease. This classification was approved by the ClinGen Congenital Heart Disease GCEP on the meeting date March 11th, 2024 (SOP Version 10).","*NFATC2* was reported in relation to autosomal dominant congenital heart disease in 2014 (Briand-Suleau, A et al., PMID: 24486774). No genetic evidence linking *NFATC2 *was identified in the literature or elsewhere. Genetic cases of *NFATC2* were seen to be a player in the congenital heart defects in patients with the 20q13.2 duplication along with* SALL4*(PMID: 24486774). \n\nFunctional alteration experimental evidence analyzed the mRNA levels in candidate CHD genes in the right ventricular myocardium of TOF cases and normal controls. Evidence found that  higher methylation of *NFATC2* might constitute a CpG island methylator phenotype for TOF disease (PMID: 24479926). In summary, the evidence supporting the relationship between *NFATC2* and autosomal dominant congenital heart disease has been disputed and no valid evidence remains to support the claim. More evidence is needed to either support or entirely refute the role *NFATC2* plays in this disease. This classification was approved by the ClinGen Congenital Heart Disease GCEP on the meeting date March 11th, 2024 (SOP Version 10)."],"dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/30f306ce-c467-4e76-a117-2082cea14aaf","GCISnapshot":"https://genegraph.clinicalgenome.org/r/6f22ef84-1ac1-412a-a134-bbe7617cf47f","calculatedEvidenceStrength":"NoKnownDiseaseRelationship","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/6f22ef84-1ac1-412a-a134-bbe7617cf47f_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10130","date":"2025-10-10T18:16:36.250Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/6f22ef84-1ac1-412a-a134-bbe7617cf47f_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10130","date":["2024-03-11T05:00:00.000Z","2024-03-11T16:00:00.000Z"],"role":"Approver"}],"curationReasonDescription":"More evidence is needed to either support or entirely refute the role NFATC2 plays in this disease. ","curationReasons":["ErrorClarification"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6f22ef84-1ac1-412a-a134-bbe7617cf47f_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6f22ef84-1ac1-412a-a134-bbe7617cf47f_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/739626c6-04c2-4812-9601-91ea04ede137","type":"EvidenceLine","dc:description":"Downgraded to be conservative in awarded points.","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c1eacd50-bd7f-44aa-b3c3-6d9815d3b11a","type":"FunctionalAlteration","dc:description":"The concurrent higher methylation of EGFR, EVC2 and NFATC2 might constitute a CpG island methylator phenotype for TOF disease and provide useful cues to understand epigenetic mechanisms in the development of TOF.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24479926","rdfs:label":"Validation of the methylation statuses of candidate genes"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/6f22ef84-1ac1-412a-a134-bbe7617cf47f_overall_genetic_evidence_line","type":"EvidenceLine","specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":0}],"evidenceStrength":"Disputed","sequence":11973,"specifiedBy":"GeneValidityCriteria10","strengthScore":0.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/LSpTtCs_wc4","type":"GeneValidityProposition","disease":"obo:MONDO_0005453","gene":"hgnc:7776","modeOfInheritance":"obo:HP_0000006"},"version":"1.1","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_6f22ef84-1ac1-412a-a134-bbe7617cf47f-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}